Skip to McMaster Navigation Skip to Site Navigation Skip to main content

Postdoc’s augmented reality solution makes pain management more accessible

Researcher and entrepreneur Stevie Foglia founded the startup Neuro-Mod, which offers augmented reality solutions for pain management, with the support of McMaster's Postdoc Entrepreneur Fellowship.

By Abigail Cukier August 26, 2025

Steve Foglia, wearing a blue suit, gestures while speaking at a podium, with a screen behind him showing a picture of him as a young adult with a man in a wheelchair.
Researcher and entrepreneur Stevie Foglia founded the startup Neuro-Mod, which offers augmented reality solutions for pain management, with the support of McMaster’s Postdoc Entrepreneur Fellowship.

When Stevie Foglia was three years old, his father was in a car accident that left him with a spinal cord injury and severe neuropathic pain.

“I’ve seen the effect this kind of pain can have on a person and their family. My dad has tried every drug and treatment and nothing has worked. It’s a matter of living through his pain every day,” says Foglia, postdoctoral fellow in the School of Biomedical Engineering.

This experience inspired Foglia to go into research for pain management with the goal of developing novel therapies that can be effective without life-altering side effects.

To help make his vision a reality, Foglia was awarded McMaster’s inaugural Postdoc Entrepreneur Fellowship in 2024. The fellowship provides $75,000 in salary support, giving postdocs more time to focus on turning their research into commercial ventures.

Foglia’s company, Neuro-Mod Inc., was born out of his doctoral research, which included work in non-invasive brain stimulation, as well as using augmented reality (AR) to deliver physiotherapy exercises.

AR makes therapy more engaging and accessible for patients, who can train in the comfort of their homes, Foglia says.

“We built this AR therapy and did this study in chronic neck pain, and we found great results in terms of pain management and improved function. The first thing patients asked us after the study was, ‘Where do I get more of this?’

“It opened our eyes, and me and my supervisor, Dr. Aimee Nelson, realized the importance of translating research to the market. Because if you can’t bridge that gap, your work may not end up helping the people it’s intended to serve.”

Alongside the fellowship, Foglia is participating in Lab2Market, a national network that provides innovation, commercialization and entrepreneurship skills training for students and researchers.

Lab2Market’s 16-week Validate program gives participants the chance to test and evaluate their ideas.

Seventy-eight interviews with patients and clinicians validated what Foglia had found in his research: Many patients lack effective pain treatment or get help through physio, but find it challenging to get to a clinic.

With validation secured, Foglia is now involved in Lab2Market Launch, a 16-week program designed to help entrepreneurs successfully launch their ventures.

Neuro-Mod is preparing for a pilot launch in physiotherapy clinics in September, and aiming for a full launch next year.

Foglia says he’s grateful for the wraparound support provided by McMaster’s entrepreneurship ecosystem.

“There is a nice synergy between the support McMaster provides their entrepreneurs and programs offered through Lab2Market,” he says.

“Coming from a STEM background, I didn’t really have training or expertise in how to build and launch a product. Lab2Market gives you guidance and knowledge on that pathway. It helps give you confidence in your product and in yourself as an entrepreneur.”

The deadline to apply for the 2025 Postdoc Entrepreneur Fellowship is Sept. 28, 2025. Join the upcoming online information session on August 27, 1 p.m. to 2 p.m. to learn more.

The deadline for the upcoming Lab2Market Launch program is Sept. 26, 2025. Join upcoming information sessions through the Lab2Market Luma calendar.

Three researchers standing side-by-side in a university laboratory.

McMaster scientists develop tech to reproduce rare medicinal molecules 

The novel technology efficiently produces lab-created copies of some of nature’s most sought-after molecules, a discovery that could accelerate broad drug development efforts.
Young woman in pain sitting on sofa, clutching pillow to tummy.

Analysis: A new saliva test for endometriosis is in trials. What this and other new endo tests mean for you

Could new tests shorten the long road to an endometriosis diagnosis? The promise is compelling, but the evidence is not there yet, write experts Mathew Leonardi and Narges Kalani.
A city shrouded in hazy smog.

Analysis: Vulnerability to wildfire smoke is in our genes, thanks to an evolutionary quirk

Mutations that occurred tens of thousands of years ago made humans uniquely sensitive to particulate air pollution, writes expert Dawn Bowdish.